Skip to main content
  • Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment.  Check your account now to learn when your revalidation is due. More information here.
Elizabeth M. Whitehorn, Director

Provider Notice Issued 07/07/2017

​

Stimulants/ADHD Agents Update to Preferred Drug List (PDL)

Date:   July 6, 2017                       

To:   Participating Pharmacies

Re:   Stimulants/ADHD Agents Update to Preferred Drug List (PDL)

_______________________________________________________________________________________

This notice informs prescribers and providers that the Department of Healthcare and Family Services (HFS) will move the brand name product Concerta to preferred status effective July 1, 2017. This change is being made in response to discontinuation of brand name Metadate CD by the manufacturer.

Please continue to dispense brand name Metadate CD until the supply chain is exhausted. When Metadate CD is no longer available, providers are encouraged to contact the patient’s doctor to request a change to another preferred long acting agent.

 

Preferred long acting methylphenidate products effective July 1, 2017 include:

 

·       Concerta brand name only

·       Focalin XR brand name only

·       methylphenidate ER-10mg, 20mg

·       methylphenidate SR-20mg

·       Metadate CD brand name only (until supply is exhausted)

·       Metadate ER-20mg

 

The Department appreciates assistance from pharmacies in this effort to ensure that, when possible, patients are proactively switched to preferred products to avoid an interruption in treatment.

 

Providers are encouraged to register on the HFS Pharmacy webpage to receive E-mail notification when changes are made to the Medicaid Preferred Drug List.

 

For questions regarding this notice, please contact a pharmacy billing consultant in the Bureau of Pharmacy Services at 877-782-5565, option 7.

 

 

Felicia F. Norwood

Director